Cargando…
Chimeric tumor modeling reveals role of partial PDL1 expression in resistance to virally induced immunotherapy
Expression of PDL1 on the surface of tumor cells can blunt the efficacy of many cancer immunotherapies. For example, our lab has previously shown that tumors derived from malignant cells incapable of expressing PDL1 are highly susceptible to immunotherapy induced by oncolytic virus treatment while t...
Autores principales: | Bartee, Mee Y., Dryja, Parker C., Bartee, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335801/ https://www.ncbi.nlm.nih.gov/pubmed/30651147 http://dx.doi.org/10.1186/s40425-018-0496-6 |
Ejemplares similares
-
Defects in intratumoral arginine metabolism attenuate the replication and therapeutic efficacy of oncolytic myxoma virus
por: Dryja, Parker, et al.
Publicado: (2023) -
TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapy
por: Valenzuela-Cardenas, Miriam, et al.
Publicado: (2022) -
Myxoma virus attenuates expression of activating transcription factor 4 (ATF4) which has implications for the treatment of proteasome inhibitor–resistant multiple myeloma
por: Dunlap, Katherine M, et al.
Publicado: (2015) -
Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virus
por: Burton, Chase, et al.
Publicado: (2019) -
Reduced cellular binding affinity has profoundly different impacts on the spread of distinct poxviruses
por: Flores, Erica B., et al.
Publicado: (2020)